Transfusion Clinique et Biologique

Papers
(The TQCC of Transfusion Clinique et Biologique is 0. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
The impact of COVID-19 pandemic on blood supplies and transfusion services in Eastern Mediterranean Region48
ABO blood group system is associated with COVID-19 mortality: An epidemiological investigation in the Indian population43
Review of indications for immunoglobulin (IG) use: Narrowing the gap between supply and demand29
COVID-19 convalescent plasma as long-term therapy in immunodeficient patients?20
Transfusion and sickle cell anemia in Africa15
Assessment of blood supply and usage pre- and during COVID-19 pandemic: A lesson from non-voluntary donation15
Post-donation information and haemovigilance reporting for COVID-19 in Greece: Information supporting the absence of SARS-CoV-2 possible transmission through blood components15
Impact of pathogen-reduction technologies on COVID-19 convalescent plasma potency14
Removing the men who have sex with men blood donation deferral: Informing risk models using Canadian public health surveillance data13
Storage of red blood cell concentrates: Clinical impact10
The impact of COVID-19 on transfusion-dependent thalassemia patients of Karachi, Pakistan: A single-center experience10
Convalescent Plasma Therapy in the management of COVID-19 patients-The newer dimensions10
Hemophilia care in Africa: Status and challenges10
Platelet transfusion practice and related transfusion reactions in a large teaching hospital8
Prevention and treatment of COVID-19-associated hypercoagulability: Recommendations of the Algerian society of transfusion and hemobiology8
Thirty years of hemovigilance – Achievements and future perspectives8
Recognizing the role of transfusion medicine specialist in the modern era8
An overview of red blood cell and platelet alloimmunisation in transfusion8
Covid-19 convalescent plasma therapy: Analyzing the factors that led to its failure in India8
Constraints and challenges in convalescent plasma collection amidst the Covid 19 pandemic- strategies and recommendations to overcome these7
Serum pooling for rapid expansion of anti-SARS-CoV-2 antibody testing capacity7
Platelet transfusion in adults: An update7
Hemolysis: Mechanism and clinico-biological consequences7
Risk factors for blood transfusion in Cesarean section: A systematic review and meta-analysis7
Adverse reactions following transfusion of blood components, with a focus on some rare reactions: Reports to the International Haemovigilance Network Database (ISTARE) in 2012–20166
Post-donation information management6
Review of blood donor deferral with emphasis on donor and patient safety6
Incidence and risk predictors analysis of adverse donor reactions in whole blood donation6
Transfusion at the border of the “intention-to-treat”, in the very aged person and in palliative care: A debate6
Cost of red blood cell transfusion; evaluation in a French academic hospital6
Is plasma donation ethics abused?6
Development of a scenario-based blood bank model to maximize reducing the blood wastage6
Variable response to therapeutic plasma exchange in pediatric anti-NMDA receptor encephalitis6
The detection, treatment of parvovirus B19 infection induced anemia in solid organ transplants: A case series and literature review of 194 patients6
Implementation of Low Titer Whole Blood for French overseas operations: O positive or negative products in massive hemorrhage?5
Real-world data from India on clinical practices in the management of autoimmune haemolytic anaemia: A survey-based cross-sectional assessment5
The effect of red blood cell transfusion on peripheral tissue oxygen delivery and consumption in septic patients5
Prevalence of HEV RNA in Croatian blood donors5
Maternal red blood cell alloimmunisation Working Party, literature review. RH blood group system: Rare specificities5
SARS-CoV-2 infection in patients with β-thalassemia: The French experience5
SARS-CoV-2 variants in immunocompromised COVID-19 patients: The underlying causes and the way forward5
Psychological assessment and lived experiences of recovered COVID-19 patients who presented for convalescent plasma donation5
A case of COVID-19 Convalescent Plasma Donation in Greece: Directed donation for compassionate use in the donor's critically ill father5
Increasing unpaid plasma collection by blood establishments to ensure availability of plasma–derived medicinal products and blood components in Europe5
Bioethical perspective of convalescent plasma therapy for COVID-19: A systematic review5
Locally harvested Covid-19 convalescent plasma could probably help combat the geographically determined SARS-CoV-2 viral variants5
COVID-19 convalescent plasma therapy and immunodeficiency5
SARS COV-2- IgG antibodies in blood donors in pandemic – A game changer for policy makers5
Seroprevalence of SARS-CoV-2 among potential convalescent plasma donors and analysis of their deferral pattern: Experience from tertiary care hospital in western India5
Positive direct antiglobulin test in COVID-19 patients: Decision-making process4
Challenges in transfusion-transmitted infection screening in Sub-Saharan Africa4
Ethics in transfusion medicine: Are the intricate layers of ethics all universal? A global view4
Emergence of ancient convalescent plasma (CP) therapy: To manage COVID-19 pandemic4
Positive anti-SARS-CoV-2 rapid serological test results among asymptomatic blood donors4
A novel scoring system for selecting the target patients of COVID-19 convalescent plasma therapy: A hypothesis4
Epidemiological aspects and molecular characterization of the hepatitis B virus among blood donors in Lubumbashi, Democratic Republic of Congo4
Trends in serological markers of transfusion transmissible infections in blood donations at the Bamenda Hospital-based Blood Service, Cameroon4
Mesenchymal – Stem and non-Stem – Cells: The name of the rose4
Indian blood donor selection guidelines: Review in the context of the ongoing COVID-19 pandemic4
O-negative blood shortage management in a university hospital: Impact of transfusing RhD-positive red blood cells to RhD-negative patients4
Significance of mandating a dedicated hemovigilance nurse and objectification of ‘imputability’ levels. Experience from a hospital-based blood centre in India4
COVID-19 vaccination in the Indian blood donors: Adjudging the impact on the deferral period4
Extended blood group phenotyping of donors from the lower and middle Himalayan region of Uttarakhand India: A pilot study4
Hereditary haematologic disorders in Najaf province-Iraq4
Efficient inactivation of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) in human apheresis platelet concentrates with amotosalen and ultraviolet A light3
Viral metagenomics in Brazilian multiply transfused patients with sickle cell disease as an indicator for blood transfusion safety3
COVID-19, transfusion, and publishing ethics3
Cytokine dependent hematopoietic cell linker (CLNK) is highly elevated in blood transfusion dependent beta-thalassemia major patients3
The Role of Artificial Intelligence in Optimizing the Donation Process and Predicting Blood Thresholds3
Nitric oxide donors offer protection to RBC from storage lesion3
Transfusion safety in the Maghreb region3
Patient blood management in adults and children: What have we achieved, and what still needs to be addressed?3
Iron-deficiency among blood donors: Donors’ opinion on iron supplementation strategy3
How do we forecast tomorrow’s transfusion: The future of hematopoietic stem cell donation3
Red-cell alloimmunization profile in multi transfused patients: Findings and insights of a blood transfusion service3
Improved neural network for predicting blood donations based on two emergent factors3
How do I/we forecast tomorrow’s transfusion? A focus on recipients’ profiles3
Positive direct antiglobulin tests in cancer patients hospitalized with COVID-19: A brief report from India3
Estimation of genetic variation in the Secretor and Lewis genes in Iranian hospitalized children3
Covid 19 vaccination: Latest guidelines on blood donor deferral in India3
Clinical performance evaluation of Elecsys HIV Duo, Anti-HCV II, HBsAg II, Anti-HBc II, and Syphilis assays for routine screening of first-time blood donor samples at a French blood donation center3
International collaboration for blood safety: The French—African experience3
Hepcidin-to-ferritin ratio: A potential novel index to predict iron overload-liver fibrosis in ß-thalassemia major3
Clinical impact of rotational thromboelastometry in cardiac surgery3
Transfusion management of Africans with RHD variants in China2
Effective and safe off-label use of caplacizumab treatment in a middle-aged obese male2
The evolution of xenotransfusions through the ages2
Estimate of anti-SARS-CoV-2 spike IgG antibodies prevalence among Iranian population based on blood donations: A serial cross-sectional study during the third wave of the pandemic2
The Indian “blood storage centre” model for the provision of safe blood towards obstetric care in the remote regions of Uttarakhand2
Building capacities in research for blood services in Africa2
Synergistic activity of vitamin-C and vitamin-E to ameliorate the efficacy of stored erythrocytes2
Retrospective analysis of molecular biology mechanism of ABO blood group typing discrepancy among blood donors in Jinan blood station2
Auto-anticorps anti-interférons de type I et COVID-19 sévère2
Transfusion management of a Chinese pregnant woman with RHD*DEL1 allele2
Transient pseudothrombocytopenia (PTCP) in the neonate due to the mother2
What are the new challenges facing blood transfusion?2
COVID-19 convalescent plasma therapy for immunodeficient patients–weighing up risks and benefits2
Deferral of men who have sex with men from blood donation: Policy and change2
Prenatal RHD genotyping in Croatia: preliminary results2
Unmet needs in β-thalassemia and the evolving treatment landscape2
The European health data space proposal: An opportunity for improved blood donor protection and transfusion recipient care2
Transfusion medicine: Overtime paradigm changes and emerging paradoxes2
There is an urgent need to adopt a pull-flow logic for the supply of RBCs to meet patients’ needs: A single center study2
Patients experienced serious adverse reactions within one hour of hematopoietic stem-cell infusion2
How do we forecast tomorrow’s transfusion? Prehospital transfusion2
The interphase between immunoglobulin, the plasma industry and the public health, managing a finite resource2
Transfusion-related respiratory complications in intensive care: A diagnosis challenge2
Pre-hospital transfusion of post-traumatic hemorrhage: Medical and regulatory aspects2
Effect of vibration of the vortex mixer on the red blood cells2
Determination of Rh type and gender using circulating cell-free fetal DNA in early pregnancy of Rh negative women in turkey2
Deciphering the reasons for milky-white blood donor plasma2
Education in transfusion medicine, Part III – The importance of haemovigilance education2
In vitro characteristics of cryopreserved platelet concentrates reconstituted by fresh frozen or lyophilized plasma2
A prospective observational study to compare transfusion outcomes in ABO identical versus ABO non-identical single donor platelet concentrates: An experience from a tertiary healthcare center in India2
Abnormal hemoglobin H band in myelodysplastic syndromes (MDS): A case report2
History of blood ‘the ' unites us all1
CL-15 Evaluation du risque résiduel de contamination bactérienne dans les concentrés plaquettaires traités par inactivation des pathogènes en France1
Serological and molecular analysis of the B(A) subtype in China—A systematic review1
COVID-19 vaccination: The impact on the selection criteria of the convalescent plasma donors1
P-122 Neutralisation par la molécule sCD38 des anti-CD38 plasmatiques en immunohématologie: une étude multicentrique1
Infectious diseases and the impact on transfusion medicine: A historical review and lessons for the future1
P-23 Un cas d’EIR grave, mais surtout de diagnostic rebelle1
CAR-T Cell Therapy in India: Challenges and Opportunities for Advancement1
Delayed adverse reaction in donors after whole blood donation: Is it a matter of concern?1
Détection de mutations de résistance du VIH aux antirétroviraux : vers un dépistage rapide pré-thérapeutique ?1
How do I/we forecast tomorrows’ transfusion: Blood components1
Evaluation of beta-thalassemia in the fetus through cffDNA with multiple polymorphisms as a haplotype in the beta-globin gene1
Strawberry milky-white blood donor's plasma: signaling uncontrolled diabetic lipemia1
L’éthique du don s’applique-t-elle de la même façon à tous les éléments du corps humain ?1
Molecular analysis and transfusion management in a rare case of cis-AB blood group: A report from India1
Implementing strategic plasma resource self-sufficiency through unpaid plasma donations on the global plasma market1
L-47 Allogreffe de cellules souches hématopoïétiques dans la drépanocytose, spécificités transfusionnelles1
Has plasma therapy failed in Covid-19 or we have failed in using it properly in India?–Lessons learned through the pandemic1
How do I forecast tomorrow’s transfusion: Are there any future and/or any breakthroughs for cell banking and transfusion medicine?1
Impact of vaccination on SARS-CoV-2 seroprevalence rate in French blood donors: An assessment as of July 20211
Red blood cell alloimmunizations in thalassaemia patients with regular transfusion in China: A systematic review and meta-analysis1
CL-01 Description et incidence des OAP mixtes TACO/TRALI en France1
Factors influencing post-cryopreserved CD34+ cells viability in the harvested products of autologous haematopoietic stem cells1
Delayed haemolytic transfusion reaction due to Kidd antibodies1
Covid-19 convalescent plasma and SARS-CoV-2 viral variants1
Comparative evaluation of DTT treated ABO isoagglutinin titres performed by two methods with solid phase red cell adhesion (SPRCA) titres1
The impact of pre-donation viral markers screening of new blood donors on blood safety1
Red cell alloimmunization in thalassaemia patients in India: Causes and mitigation strategies1
Reverse algorithm for screening of syphilis and trends in prevalence among blood donors in Coastal Karnataka1
How do we forecast tomorrow’s transfusion? — Next generation transfusion practices to improve recipient safety1
P-08 Vers un système d[StQuote]hémovigilance efficace et pérenne en Afrique francophone1
Molecular frequency of human gemycircularvirus (GCYV) dna among blood donors from the Brazilian Amazon1
Prevalence and factors associated with vasovagal reaction among whole blood donors in hospital Universiti Sains Malaysia1
Positive direct antiglobulin tests in cancer patients on immune checkpoint inhibitors: A case series from India1
How do I/We forecast tomorrow’s transfusion? A series of experts’ proposals for changes in transfusion medicine1
The battle against Thalassemia in Pakistan: Way to move forward1
Inactivation des pathogènes par le procédé Intercept® dans les concentrés plaquettaires : bilan de 3 ans de généralisation en France1
Accurate detection of reemergent anti-donor ABO antibody is crucial for safe transfusion in ABO major incompatible HSCT patient after achieved the stages of full switch to donor type1
Vaccination and SARS-CoV-2 seroprevalence in blood donors: Correspondence1
Role of Therapeutic Plasma Exchange in managing complement mediated thrombotic microangiopathy  – Case series1
Don’t neglect the rare adverse event with intravenous immunoglobulin: Hemolytic anemia1
Homing of granulocytes transfused in perineal cellulitis in a RAC2 deficiency child monitored by chimerism quantification methods1
Platelet transfusion therapy in the management of dengue patients: Role of fundus examination1
P-177 Place de la transfusion sanguine dans la prise en charge thérapeutique de l[StQuote]anémie sévère chez les patients suivi pour rectocolite hémorragique1
Impact of pathogen reduction technology on neutralizing antibody titer in COVID-19 convalescent plasma1
Does intraoperative transfusion during total knee arthroplasty reduce the need for transfusion after surgery?: A preliminary retrospective cohort study1
Implementation of Indian National plasma policy at blood bank of a tertiary care hospital: A step towards strengthening of blood transfusion services1
The appropriateness of platelet transfusions in hematological patients and the potential for improvement1
Regulation of blood services in Africa1
L-48 Alloimmunisation et drépanocytose1
What convalescent plasma in treating severe acute respiratory infections of viral aetiology can hint for COVID-19? Evidence from a meta-analysis1
Transfusional iron overload in heavily transfused patients: Real-life data from a 10-year retrospective study of 611 cases managed in a French general hospital1
Utilisation patterns of group O red blood cell transfusion by ABO and D non-identical recipients in large academic hospital1
An audit to estimate the quality of practices followed during bedside blood transfusion in a tertiary care hospital and role of continuous medical education in it1
Reporting of delayed adverse donor reactions in whole blood donors: Just the tip of an iceberg!1
How do we forecast tomorrow’s transfusion? Applying social science approaches to meet tomorrow’s transfusion needs: Blood donors and donation1
Haploidentical haematopoietic stem cell transplantation for the treatment of severe aplastic anaemia patients with high-risk factors who lack an HLA-matched sibling donor1
Towards equitable and sustainable availability of blood products in Zimbabwe: An analysis of strengths, weaknesses, opportunities and challenges1
How do we forecast tomorrow’s transfusion: Infectious safety?1
What is the optimal pretransfusion testing interval for multi-transfused patients? The University Hospital of Brest experience1
Detection of asymptomatic Leishmania donovani in healthy voluntary blood donors1
The AfSBT Step-wise Accreditation program: Improving the quality in the African blood services1
Covid-19 induced blood supply shortage: A Tunisian blood deposit perspective1
Maîtrise du risque transfusionnel en ES : réflexion sur la démarche a priori des risques1
Carence en fer chez les donneurs de sang en France : état des lieux et perspectives de prévention1
Blood-Type-A is a COVID-19 infection and hospitalization risk in a Turkish cohort1
Modèle de transfusion in vitro pour étudier les globules rouges1
Significant decrease in the transfusion rates during the COVID-19 pandemic in the North East of Iran1
Reporting an abrupt-onset persistent hypotensive transfusion reaction in an Indian female patient1
Frequency of the ‘Asia type’ DEL with weak D phenotype in chinese1
Current challenges of blood transfusions in patients with thalassemia in India and future perspectives1
Impact of blood donor characteristics on quality of packed red blood cell concentrates1
Early and persistent viral clearance in COVID-19 patients treated with convalescent plasma1
A case of severe hemolytic disease of newborn due to alloimmunization in primigravida1
Advancing blood transfusion safety using molecular detection in the country of Georgia1
How we forecast tomorrow’s haemovigilance1
Averting transfusion related catastrophe during blood administration: Backing transfusion bioethics1
L-34 PBM - Gestion Personnalisée du Capital Sanguin du Patient en Péri-opératoire1
The impact of a closed-loop electronic blood transfusion system on transfusion errors and staff time in a children's hospital1
Blood inventory management strategies to ensure adequacy of packed red blood cell stock1
Renaissance in usage of excess plasma in blood banks1
The best use of the French donors’ gift – Continuing an ethical tradition1
Zeroing in on the root cause of the clots in a blood bag: Reinforcing improvement in blood collection practices1
How do we forecast tomorrows’ transfusion: Non-transfusional hemotherapy1
L-51 Gestion de l’hémorragie du post-partum0
L-18 Les erreurs de receveurs et de patients destinataires de produits sanguins labiles (PSL) : données nationales et européennes0
P-018 Déterminants de la faible mobilisation des populations au don0
P-17 Le TRALI (Transfusion Related Lung Injury) à l’unité d’hémovigilance du CRTS de Sfax, Tunisie0
CO4-1 Implementation in France of a new method for cryopreserved platelets with minimal post-thaw processing0
P-46 Risque résiduel de transmission du virus de l’hépatite C au Centre de Transfusion Sanguine de Yamoussoukro, Côte d’Ivoire, de 2017 à 20200
A comparative evaluation of the quality of cryoprecipitate prepared from 350 ml versus 450 ml of whole blood and different methods of thawing of plasma: A prospective observational study0
P-61 Ethique transfusionnelle : quelle décision prendre ?0
Endorsing the enrolment of transplantation centers into the hematopoietic stem cell donor registries: An Indian perspective0
Challenges in management of atypical hemolytic uremic syndrome: Bottle neck in resource limited settings0
CL-05 Automatisation du titrage des anticorps anti-A et anti-B naturels et immuns0
Comparative evaluation of oxidative and biochemical parameters of red cell concentrates (RCCs) prepared from G6PD deficient donors and healthy donors during RCC storage0
Expression of microRNAs during apheresis platelet storage up to day 14 in a blood bank in China0
SARS-CoV-2 neutralizing capacity among blood donors without prior COVID-19 symptomatic history vs. blood donors with prior COVID-19 symptomatic history: A comparative study0
What has changed after the COVID-19 pandemic in the publication process? A look-back to “Transfusion clinique et biologique”0
Anti-SARS-CoV-2 spike IgG antibodies prevalence: Correspondence0
P-03 La formation continue en sécurité transfusionnelle au CHU de Dijon : Comment l’améliorer ?0
L-27 L’importance de l’animation de la formation0
Séroprévalences des hépatites virales B et C, de 2017–20200
L-10 Approvisionnement des Dépôts de Délivrance en EFS Occitanie0
CO7-4 Acceptabilité d’un questionnaire non genré chez les donneurs d’Héma-Québec et intention de retourner faire un don0
CL-10 Développement d’un outil informatique de surveillance des PSL présents dans les Dépôts d’Urgence Vitale de la région Occitanie0
CO2-5 Modulation du phosphoprotéome et morphologie des globules rouges stockés0
CL-17 Réalisation des prélèvements pour phénotypage érythrocytaire : une nouvelle enquête multicentrique et des pistes pour aller plus loin0
Comparative Evaluation of Hematological Parameters and Instrument Performance in Single and Double Plateletpheresis Procedures Using Haemonetics MCS+ and Trima Accel Systems0
L-62 Transfusion et patients COVID-19 au cours de la 1ère vague0
An assessment of clinical and laboratory impact in a resource constraint setting: Does Rh and Kell phenotyping of donor units complement type and screen method of compatibility testing?0
Is high hemoglobin a hindrance factor for blood donation? A pilot observational study from the coastal region of India0
P-38 Fiabilité des hémoglobinomètres utilisés au Centre National de Transfusion Sanguine d’Abidjan, Côte d’Ivoire0
Editorial Board0
Intraoperative and immediate postoperative transfusion: Clinical-hematological profile of transfunded patients in a university hospital0
Distribution of ABO alleles in the Northeast Algerian population0
Revisiting the impact of serial therapeutic phlebotomy in polycythaemia on laboratory and clinical parameters using a fixed interval and fixed volume protocol0
P-50 Gestion des CGR irradiés en HFNO0
Editorial Board0
L-61 Transfusion sanguine en Opération Extérieure : retour d’expérience d’une mission de l’opération Barkhane0
P-023 Impact de la période estivale sur l’incidence des réactions vasovagales de grade supérieur ou égal à 2 en région Occitanie Pyrénées Méditerranée0
L-54 Le « patient blood management » dans la démarche RAAC0
CO3-6 Etude de l[StQuote]évolutivité de la vasculopathie cérébrale et des événements vaso-occlusifs selon le taux d[StQuote]HbS chez des patients drépanocytaires en programme transfusionnel0
P-54 Le protocole transfusionnel donneur unique (PDU) en néonatalogie : vision du néonatalogiste0
Table des matières0
L-28 L’évaluation de la formation : une nécessité pour tous0
Alteration in biochemical parameters during plateletpheresis in healthy donors: A compendious analysis0
Therapeutic plasma exchange as a treatment modality for steroid refractory acute disseminated encephalomyelitis – A case report0
P-59 Formateur une passion en mouvement0
Plateletpheresis donation through donor awareness, motivation, and recruitment drives: A unique concept and experience from a tertiary care oncology centre in India0
Traitement du purpura thrombotique thrombocytopénique auto-immun : un tournant décisif0
Unexpected increase of the compliance rate of transfusion requisition form after the COVID-19 outbreak0
Blood donation by extreme medial basilic vein0
No difference in myocardial iron concentration and serum ferritin with deferasirox and deferiprone in pediatric patients with hemoglobinopathies: A systematic review and meta-analysis0
P-18 Anticorps anti-MNS4 non hémolysant chez une multipare0
0.16465997695923